Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Por Regan, Meredith M., Pagani, Olivia, Fleming, Gini F., Walley, Barbara A., Price, Karen N., Rabaglio, Manuela, Maibach, Rudolf, Ruepp, Barbara, Coates, Alan S., Goldhirschi, Aron, Colleoni, Marco, Gelber, Richard D., Francisl, Prudence A.
Publicado em 2013

Evaluating Letrozole and Tamoxifen Alone and in Sequence for Postmenopausal Women with Steroid Hormone Receptor-Positive Breast Cancer: the BIG 1-98 Randomized Clinical Trial at 8....

Por Regan, Meredith M., Neven, Patrick, Giobbie-Hurder, Anita, Goldhirsch, Aron, Ejlertsen, Bent, Mauriac, Louis, Forbes, John F., Smith, Ian, Láng, István, Wardley, Andrew, Rabaglio, Manuela, Price, Karen N., Gelber, Richard D., Coates, Alan S., Thürlimann, Beat
Publicado em 2011

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

Por Chirgwin, Jacquie H., Giobbie-Hurder, Anita, Coates, Alan S., Price, Karen N., Ejlertsen, Bent, Debled, Marc, Gelber, Richard D., Goldhirsch, Aron, Smith, Ian, Rabaglio, Manuela, Forbes, John F., Neven, Patrick, Láng, István, Colleoni, Marco, Thürlimann, Beat
Publicado no J Clin Oncol (2016)

Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

Por Ewertz, Marianne, Gray, Kathryn P., Regan, Meredith M., Ejlertsen, Bent, Price, Karen N., Thürlimann, Beat, Bonnefoi, Hervé, Forbes, John F., Paridaens, Robert J., Rabaglio, Manuela, Gelber, Richard D., Colleoni, Marco, Láng, István, Smith, Ian E., Coates, Alan S., Goldhirsch, Aron, Mouridsen, Henning T.
Publicado em 2012

Treatment-Associated Musculoskeletal and Vasomotor Symptoms and Relapse-Free Survival in the NCIC CTG MA.27 Adjuvant Breast Cancer Aromatase Inhibitor Trial

Por Stearns, Vered, Chapman, Judith-Anne W., Ma, Cynthia X., Ellis, Matthew J., Ingle, James N., Pritchard, Kathleen I., Budd, G. Thomas, Rabaglio, Manuela, Sledge, George W., Le Maitre, Aurélie, Kundapur, Jessica, Liedke, Pedro E.R., Shepherd, Lois E., Goss, Paul E.
Publicado no J Clin Oncol (2015)

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial

Por Johansson, Harriet, Gray, Kathryn P., Pagani, Olivia, Regan, Meredith M., Viale, Giuseppe, Aristarco, Valentina, Macis, Debora, Puccio, Antonella, Roux, Susanne, Maibach, Rudolf, Colleoni, Marco, Rabaglio, Manuela, Price, Karen N., Coates, Alan S., Gelber, Richard D., Goldhirsch, Aron, Kammler, Roswitha, Bonanni, Bernardo, Walley, Barbara A.
Publicado no Breast Cancer Res (2016)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

Por Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Publicado em 2013

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial

Por Goss, Paul E., Ingle, James N., Pritchard, Kathleen I., Ellis, Matthew J., Sledge, George W., Budd, G. Thomas, Rabaglio, Manuela, Ansari, Rafat H., Johnson, David B., Tozer, Richard, D'Souza, David P., Chalchal, Haji, Spadafora, Silvana, Stearns, Vered, Perez, Edith A., Liedke, Pedro E.R., Lang, Istvan, Elliott, Catherine, Gelmon, Karen A., Chapman, Judy-Anne W., Shepherd, Lois E.
Publicado em 2013